scholarly journals "Conceptual study of the Anukta Vyadhi w. s. r. to Covid-19 Disease."

Author(s):  
Dr. Ansari Huma ◽  
Pravin Patil ◽  
Arun Dudhamal

Covid –19 or Novel Coronavirus is a disease originally distinguished in China at the end of 2019, has caused an enormous worldwide flare-up and a significant general medical problem. Henceforth, WHO has pronounced Coronavirus as the sixth public health emergency of global concern. To forestall the spread of this infection all nations had powerfully placed lockdown. Since no vaccine has been affirmed till now the triads of early evaluating, isolating, and treating the patients were trailed by different medical services places. It is more predominant among the old-aged related to comorbidities and in immunosuppressed. Since this condition is related to numerous complications on many systems, clinical features ranging from asymptomatic to SARS, pneumonia to death of an individual, it has become a need to study this illness fundamentally. Coronavirus is a new disease entity for the Ayurveda which comes under Janapadodhwanasa (worldwide epidemic), Upasargika vyadhi (communicable diseases), and Anukta vyadhi. The term Anukta is used in the sense of unuttered, unsaid, and unheard. The Concept of Anukta is one such time-tested principle that is useful to understand the new disease, drug, and formulations. Covid19 isn't mentioned in traditional writings of Ayurveda yet with the guideline of Anukta vyadhi the pathogenesis, the management, and prevention of the illness can be perceived. 

Author(s):  
Neelam Vinod Motwani ◽  
Abhilash Ulhas Dudhekar ◽  
Pramita Ambadas Muntode

In 2019 December, a bunch of respiratory disorder cases associated with city’s South China seller spot for sea food of unknown pathology was identified by the health authorities of Wuhan, China. And has been designated a public health emergency of international concern. Consequently, it was concluded that the virus spreads from individual-to-individual, and carriers are the most common source of Coronavirus growth. Novel Coronavirus, SARS–COV-2, was revealed by subsequent investigations and that was the initiative agent now at the core of a major outburst. To prevent or to reduce transmission, special focus and efforts were applied to vulnerable population including elderly people, children and health workers. And large scale measures were taken to lower communicable spread of COVID-19 from surveying a relation of (SARS) Severe Acute Respiratory Syndrome and (MERS) Middle East Respiratory Syndrome, where beta corona virus, which strike the lower respiratory tract and shows pneumonia in human being, was the causative agent. WHO announced outbreak of COVID-19 in the early First light of January 31, 2020 (Korea Standard Time) as “Public Health Emergency of International Concern” (PHEIC).An important collective goal was to reduce the outbreak and to flatten the peak of the outbreak curve. Delays result in significantly higher death tolls. In this review, we are trying to highlight the clinical features, investigations, WHO declaration of PHEIC, mode of transmission, effective Infection protocol to prevent this virulent infection from expansion and WHO 5 Movements because Hand Washing is a way of disinfecting a person’s hands that considerably decreases likely pathogens (deadly germs) on the palms.


Author(s):  
Nusrat Mannan ◽  
Arifa Akram

In December 2019, the novel coronavirus (2019-nCoV) outbreak, began in China, which has now spread many countries around the globe in a form of pandemic, with the number of confirmed cases increasing every day. With a death toll exceeding that of the SARS-CoV outbreak, 2019-nCoV has led to a public health emergency of international concern, putting all health organizations around the world on a high alert. Here, we presented an overview of the currently available information on the clinical presentation and complication of this virus. Bangladesh Journal of Infectious Diseases, April 2020;7(suppl_1):S54-S57


2021 ◽  
Vol 1 (1) ◽  
pp. 7-8
Author(s):  
Solomon Arigwe Joseph ◽  
Abuhuraira Ado Musa ◽  
Faisal Muhammad ◽  
Tijjani Muhammad Ahmad

People began to become ill in late December 2019 in Wuhan, Hubei Province, China, and the illness was revealed to be a kind of pneumonia with unusual signs and symptoms. It was eventually discovered as a novel coronavirus, a virus that causes widespread sickness in animals and birds. World Health Organization (WHO) named this new viral disease coronavirus disease 2019 (COVID-19) and declared a Public Health Emergency of International Concern in January 2020.


Author(s):  
Subhashis Debnath ◽  
Runa Chakravorty ◽  
Donita Devi

In December 2019, severe acute respiratory syndrome-coronavirus-2, a novel coronavirus, initiated an outbreak of pneumonia from Wuhan in China, which rapidly spread worldwide. The outbreak was declared as “a public health emergency of international concern” by the WHO on January 30, 2020, and as a pandemic on March 11, 2020. The disease is transmitted by inhalation or contact with infected droplets and the incubation period ranges from 2 to 14 d. The symptoms are usually fever, cough, sore throat, breathlessness, fatigue, malaise among others. The disease is mild in most people; in some (usually the elderly and those with comorbidities), it may progress to pneumonia, acute respiratory distress syndrome (ARDS) and multi organ dysfunction. Many people are asymptomatic. The virus spreads faster than its two ancestors the SARS-CoV and Middle East respiratory syndrome coronavirus (MERS-CoV), but has lower fatality.


Sensors ◽  
2020 ◽  
Vol 20 (22) ◽  
pp. 6591
Author(s):  
Badriyah Alhalaili ◽  
Ileana Nicoleta Popescu ◽  
Olfa Kamoun ◽  
Feras Alzubi ◽  
Sami Alawadhia ◽  
...  

The coronavirus disease 2019 (COVID-19) pandemic is considered a public health emergency of international concern. The 2019 novel coronavirus (2019-nCoV) or severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that caused this pandemic has spread rapidly to over 200 countries, and has drastically affected public health and the economies of states at unprecedented levels. In this context, efforts around the world are focusing on solving this problem in several directions of research, by: (i) exploring the origin and evolution of the phylogeny of the SARS-CoV-2 viral genome; (ii) developing nanobiosensors that could be highly effective in detecting the new coronavirus; (iii) finding effective treatments for COVID-19; and (iv) working on vaccine development. In this paper, an overview of the progress made in the development of nanobiosensors for the detection of human coronaviruses (SARS-CoV, SARS-CoV-2, and Middle East respiratory syndrome coronavirus (MERS-CoV) is presented, along with specific techniques for modifying the surface of nanobiosensors. The newest detection methods of the influenza virus responsible for acute respiratory syndrome were compared with conventional methods, highlighting the newest trends in diagnostics, applications, and challenges of SARS-CoV-2 (COVID-19 causative virus) nanobiosensors.


2020 ◽  
Vol 42 ◽  
pp. e2020006 ◽  
Author(s):  
Sukhyun Ryu ◽  
Byung Chul Chun

OBJECTIVES: The 2019 novel coronavirus (2019-nCoV) from Wuhan, China is currently recognized as a public health emergency of global concern.METHODS: We reviewed the currently available literature to provide up-to-date guidance on control measures to be implemented by public health authorities.RESULTS: Some of the epidemiological characteristics of 2019-nCoV have been identified. However, there remain considerable uncertainties, which should be considered when providing guidance to public health authorities on control measures.CONCLUSIONS: Additional studies incorporating more detailed information from confirmed cases would be valuable.


2020 ◽  
Author(s):  
Tiantian Zhang ◽  
Wenming Shi ◽  
Ying Wang ◽  
Ge Bai ◽  
Ruiming Dai ◽  
...  

AbstractBackgroundThe novel coronavirus disease 2019 (COVID-19) outbreak is spreading rapidly throughout China and the world. Hence, early surveillance and public health emergency disposal are considered crucial to curb this emerging infectious disease. However, studies that investigated the early surveillance and public health emergency disposal for the prevention and control of the COVID-19 outbreak in China are relatively few. We aimed to compare the strengths and weaknesses of early surveillance and public health emergency disposal for prevention and control between COVID-19 and H7N9 avian influenza, which was commended by the international community, in China.MethodsA case-comparison study was conducted using a set of six key time nodes to form a reference framework for evaluating early surveillance and public health emergency disposal between H7N9 avian influenza (2013) in Shanghai, China and COVID-19 in Wuhan, China.FindingsA report to the local Center for Disease Control and Prevention, China, for the first hospitalized patient was sent after 6 and 20 days for H7N9 avian influenza and COVID-19, respectively. In contrast, the pathogen was identified faster in the case of COVID-19 than in the case of H7N9 avian influenza (12 days vs. 31 days). The government response regarding COVID-19 was 10 days later than that regarding avian influenza. The entire process of early surveillance and public health emergency disposal lasted 5 days longer in COVID-19 than in H7N9 avian influenza (46 days vs. 41 days).ConclusionsThe identification of the unknown pathogen improved in China between the outbreaks of avian influenza and COVID-19. The longer emergency disposal period in the case of COVID-19 could be attributed to the government’s slower response to the epidemic. Improving public health emergency management could lessen the adverse social effects of emerging infectious diseases and public health crisis in the future.ContributorsTZ, WS, and LL designed the project, processed and analyzed the data, and wrote the manuscript. YW, GB, RD, and QW edited the manuscript. All authors revised the draft.


2021 ◽  
Vol 75 ◽  
pp. 91-100
Author(s):  
Arezoo Mirzaei ◽  
Sharareh Moghim

The recent continuously emerging rampancy of novel coronavirus (SARS-CoV-2) that started in Wuhan in late December 2019 has become an international public health emergency and is still spreading rapidly in the world. Up to October 11, 2020, 37.109.6851 confirmed cases of COVID-19 have been announced with 2.8 percent death, which means 1.070.355 confirmed death cases. At the moment, a specific vaccine or drug for the new coronavirus is not available; thus, the development of a drug with far-reaching HCoV inhibitory activity is an urgent medical need. It is, however, vital to first comprehend the nature of this family and other coronaviruses that have caused the outbreak. Here, we relate the epidemiological and virological characteristics of the COVID-19, SARS, and MERS rampancy.


Author(s):  
Gitashree Dutta ◽  
Tarun Kumar

World Health Organization (WHO) considered the outbreak of a novel coronavirus, COVID-19, to be a Public Health Emergency of International Concern on January 2020 and finally on March 2020, WHO declared COVID-19 as a pandemic.


2020 ◽  
Author(s):  
Qin Chen

UNSTRUCTURED The outbreak of novel coronavirus pneumonia has been declared a public health emergency of international concern by World Health Organization since January 30, 2020 and the new coronavirus pneumonia was named Corona Virus Disease 2019(COVID-19) in February 11th. Novel coronavirus has been effectively controlled in China, but has spread worldwide and been epidemic in some countries. By March 30th, more than 600 thousand people were confirmed infected in areas other than China, and increased by more than 50 thousand people per day3. Our hospital is a district-level public hospital directly under the Jinniu District Government. Since February 5, our hospital has been listed by the Chengdu Municipal Government as the primary designated medical unit for treating new crown patients in Jinniu District.Recently, how to deal with COVID-19 more effectively and interrupt the transmission has become the concern of medical staff. Now we will share our experience on COVID-19 with you.


Sign in / Sign up

Export Citation Format

Share Document